Issue 1, 2014
From the journal:

Inorganic Chemistry Frontiers

Influence of an anti-metastatic ruthenium(iii) prodrug on extracellular protein–protein interactions: studies by bio-layer interferometry†

Aviva Levinaa  and  Peter A. Lay*a  

* Corresponding authors

a School of Chemistry, Room 307, F11, The University of Sydney, Sydney, NSW 2006, Australia
E-mail: peter.lay@sydney.edu.au
Fax: +61-2-93513329
Tel: +61-2-93514269

Abstract

In the first application of bio-layer interferometry in medicinal inorganic chemistry, Fe(III)–transferrin (Tf) binds strongly to Tf receptor 1 (TfR1), but an apo–Tf adduct of the anti-metastatic prodrug, NAMI-A does not bind specifically to TfR1. Binding of NAMI-A to albumin affects its interactions with other blood proteins, such as immunoglobulins.

Graphical abstract: Influence of an anti-metastatic ruthenium(iii) prodrug on extracellular protein–protein interactions: studies by bio-layer interferometry

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C3QI00054K
Article type
Communication
Submitted
27 sen 2013
Accepted
14 noy 2013
First published
16 dek 2013
This article is Open Access
Creative Commons BY license

Inorg. Chem. Front., 2014,1, 44-48

Permissions

Request permissions

Influence of an anti-metastatic ruthenium(III) prodrug on extracellular protein–protein interactions: studies by bio-layer interferometry

A. Levina and P. A. Lay, Inorg. Chem. Front., 2014, 1, 44 DOI: 10.1039/C3QI00054K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements